Mike P @MikeBio6

Trading Bio to be financially independent. Sharing my Logical and financial assumptions In a way that everyone of us can understand. Joined September 2020

Tweets

1K
Followers

278
Following

122
Likes

543

Mike P @MikeBio6

4 days ago

$KOD What does not make sense 1)Valuation. 2) Trial design. 3) CEO exercising his options a week before trial results . To add to this I think shorts are playing hard on it and making it go more higher in the trading playground.

0 1 2 156 0

View Details

Mike P @MikeBio6

5 days ago

@DescartesIdea @AscendingBio Looking at the data and the real points raised. I would be surprised if FDA approves this without 2 year data.

1 0 0 85 0

View Details

Mike P @MikeBio6

5 days ago

@AscendingBio $KOD how did they even design a trial like this?. Is it not questionable?.

2 0 1 479 0

View Details

Mike P @MikeBio6

3 weeks ago

@zipjet $TGTX all the prior buy backs were done when the price is below 30 . Based on what I see they would not be spending on buy backs unless the stock drops below 40 / 45 at this point.

1 0 2 444 0

View Details

Mike P @MikeBio6

3 weeks ago

@Lucy3370 $TGTX This is solid the growth continues.

0 0 2 138 0

View Details

Mike P @MikeBio6

3 weeks ago

$TGTX what's the point in having two conversations within a matter of one week when materially nothing would change.

TG Therapeutics @TGTherapeutics

3 weeks ago

#SaveTheDate – Join the Fireside Chat with TG's CEO Mike Weiss at the H.C. Wainwright 28th Annual Global Investment Conference. Webcast on Monday, Sept. 14th at 12:00PM ET at ir.tgtherapeutics.com/events $TGTX @HCWCO #HCWConference #FearlessForPatients

0 3 16 2K 0

2 0 3 2K 0

View Details

Mike P @MikeBio6

a month ago

$TGTX weird day and weird price action.🤔

0 0 2 191 0

View Details

Mike P @MikeBio6

a month ago

@Lucy3370 $TGTX that was something on a big red day and with big weakness in first hour.

0 0 2 240 0

View Details

Mike P @MikeBio6

a month ago

@Lucy3370 @TheWolfOfFrank2 @thegunnerab $TGTX Why would someone buy puts for an 80 strike now?. This is not making sense to me. This looks purely for the purpose of manipulation or a put being executed instead of call.

1 0 0 393 0

View Details

Mike P @MikeBio6

a month ago

$TGTX wow looks like it’s a status quo. No one wants to part with their shares and no one is willing to pay more than the current price to grab them. Shorts can easily pounce in such a condition and create panic selling. Let’s see where it goes.

0 0 3 602 1

View Details

Mike P @MikeBio6

a month ago

@zipjet 🤣🤣🤣🤣🤣🤣

0 0 0 25 0

View Details

Mike P @MikeBio6

a month ago

@BehroozNajafi @YYDSxjm You could be right too. I do not see any volume at all for the last 2 days. Looks like regular trading as usual. Even at this price I see $TGTX valuation far below that what it should be.

1 0 4 836 0

View Details

Mike P @MikeBio6

a month ago

$TGTX random walk all over the place. None of the volume shows any covering from the shorts. Looks like shorts are confident \ careless at this point. Another strange behavior before end of the day for the last 3 days the price is being kept more than 3-4 percent than high of day

0 0 5 540 0

View Details

Mike P @MikeBio6

a month ago

@WisemanCap Very interesting and highly immature to make such kind of statements. Based on this AI is expected to cover 50 percent of global revenues 🤦‍♂️🤦🤦‍♀️

0 0 0 140 0

View Details

Mike P @MikeBio6

a month ago

@familyoffice47 @BehroozNajafi Ooops !!!!. I am not a bot nor did I copy anything from anywhere.

0 0 0 10 0

View Details

Mike P @MikeBio6

a month ago

@BehroozNajafi @YYDSxjm $TGTX I do not think this was a pump and dump. Someone had some news. they picked up options most probably as a safety for short positions.Price action and options movement for the next one month would determine if there is a near term sale of the company.

1 0 8 733 0

View Details

Mike P @MikeBio6

a month ago

@Biotech2050 your are spot on $TGTX . In all the prior quarters it has repurchased shares as and when possible and previous quarter was the one in the last 6 quarters where the 1) program was authorized , 2) amount was there to purchase. 3)Stock price in low 30's still no repurchases happened

0 0 5 441 0

View Details

Mike P @MikeBio6

a month ago

@Biotech2050 $TGTX The two candidate explanations: (a)Contingency capacity: The March increase was headroom,not intent. (b)MNPI blackout: If deal discussions began during Q2 2026, suspending buybacks is standard legal practice. A hard stop of $100M/quarter to $0 immediately post-authorization

0 0 1 345 0

View Details

Mike P @MikeBio6

a month ago

@Biotech2050 Why this pattern matters: A company that front-loads $100M into a single quarter, fills the program to within $8K of the limit, triples the authorization in the same month — and then buys nothing for the entire next quarter while holding $482M cash — is behaving unusually.